FEAU

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameFEAU
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtivesSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA inhibitors
TargetsDNA
Therapy Area/IndicationsHerpesviridae InfectionsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBerlex Biosciences Inc
Active IndicationsN/A
Inactive IndicationsHerpesviridae InfectionsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A